National Key R&D Program of China (NO.2019YFC1316204)
The peptide CDMO market, valued at approximately $4.14 billion in 2025, is forecast to reach $9.84 billion by 2031 at a compound annual growth rate of 15.5%
They think, works in the gut, decreases your appetite
Phase II detoxification is typically associated with conjugation reactions like glucuronidation, sulfation, and glutathione conjugation, but there is a parallel set of Phase II enzymes that do not conjugate anything
If you're a busy professional who struggles to maintain consistent oral supplementation, IV therapy cuts through that challenge entirely
Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome